EP1755978A1 - Medicament housing apparatus having outer and inner containers - Google Patents

Medicament housing apparatus having outer and inner containers

Info

Publication number
EP1755978A1
EP1755978A1 EP05749362A EP05749362A EP1755978A1 EP 1755978 A1 EP1755978 A1 EP 1755978A1 EP 05749362 A EP05749362 A EP 05749362A EP 05749362 A EP05749362 A EP 05749362A EP 1755978 A1 EP1755978 A1 EP 1755978A1
Authority
EP
European Patent Office
Prior art keywords
container
packaging system
outer container
inner container
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05749362A
Other languages
German (de)
French (fr)
Inventor
Fred Mieras c/o GlaxoSmithKline KILLINGER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1755978A1 publication Critical patent/EP1755978A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D23/00—Details of bottles or jars not otherwise provided for
    • B65D23/12—Means for the attachment of smaller articles
    • B65D23/14—Means for the attachment of smaller articles of tags, labels, cards, coupons, decorations or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D1/00—Rigid or semi-rigid containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material or by deep-drawing operations performed on sheet material
    • B65D1/02—Bottles or similar containers with necks or like restricted apertures, designed for pouring contents
    • B65D1/0223—Bottles or similar containers with necks or like restricted apertures, designed for pouring contents characterised by shape
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D11/00—Containers having bodies formed by interconnecting or uniting two or more rigid, or substantially rigid, components made wholly or mainly of plastics material
    • B65D11/16—Containers having bodies formed by interconnecting or uniting two or more rigid, or substantially rigid, components made wholly or mainly of plastics material with double walls
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2203/00—Decoration means, markings, information elements, contents indicators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2203/00—Decoration means, markings, information elements, contents indicators
    • B65D2203/10—Transponders

Definitions

  • the invention generally relates to packaging for housing medicament.
  • packaging pharmaceutical medicament present in oral dosage form are disclosed. Specific examples include those intended to accommodate packaging a variety of predetermined volumes of medicament.
  • U.S. Patent Nos. 5,315,81 1 ; 5,197,602; and 6,243,936 disclose packaging systems for containing materials therein, and methods for assembling packaging systems for containing materials. Notwithstanding any potential advantages offered by the above- proposed packaging systems, such systems may be potentially complicated from an assembling perspective in that an individual packaging system is made up of multiple components. It would be desirable to obtain a packaging system that is simpler in structure, thus having the potential to reduce multiple steps in assembling a conventional packaging system.
  • the present invention provides a packaging system.
  • the packaging system includes a plurality of substantially uniformly shaped containers comprising an outer container and an inner container present within the outer container.
  • the outer container includes a flange and a container wall attached thereto and extending downwardly from the flange.
  • the inner container includes a container wall and a bottom portion attached to the container wall which closes the inner container. Both the outer container and the inner container each have respective cross-sections.
  • the outer container has a bottom portion that is not enclosed, and a void space is present between the outer container and the inner container.
  • the inner container further includes a neck having a base portion and wherein the flange of said outer container is attached to the base portion.
  • FIGS. 1a and 1b respectively are side and bottom cross-sectional views of an embodiment of the packaging system.
  • FIG. 2 is a perspective view of an embodiment of the packaging system.
  • FIGS. 3a and 3b respectively are side and bottom cross-sectional views of an embodiment of the packaging system.
  • FIG. 4 is a perspective view of an embodiment of the packaging system.
  • FIG. 5 is a perspective view of an embodiment of an array of packaging systems.
  • a number of materials may be employed in forming the outer and inner containers of the invention.
  • these may be formed from a polymer, preferably one or more thermoplastic polymers.
  • Exemplary polymers include at least one material such as, without limitation, polyvinyl chloride, polyvinylidene chloride, polypropylene, polyethylene, polychlorotrifluoroethylene, and combinations thereof.
  • the packaging system of the present invention may be fabricated by employed accepted techniques such as, without limitation, injection molding. At least one medicament may be housed in the packaging system of the present invention.
  • the term “medicament”, as used herein, is meant to mean and include any substance (i.e., compound or composition of matter) which, when administered to an organism (human or animal) induces a desired pharmacologic and/or physiologic effect by local and/or systemic action.
  • the term therefore encompasses substances traditionally regarded as actives, drugs and bioactive agents, as well as biopharmaceuticals (e.g., peptides, hormones, nucleic acids, gene constructs, etc.) typically employed to treat a number of conditions which is defined broadly to encompass diseases, disorders, infections, and the like.
  • Exemplary medicaments include, without limitation, antibiotics, antivirals, H 2 -receptor antagonists, 5HT ⁇ agonists, 5HT 3 antagonists, COX2-inhibitors, medicaments used in treating psychiatric conditions such as depression, anxiety, bipolar condition, tranquilizers , medicaments used in treating metabolic conditions, anticancer medicaments, medicaments used in treating neurological conditions such as epilepsy and Parkinsons Disease, medicaments used in treating cardiovascular conditions, non-steroidal anti-inflammatory medicaments, medicaments used in treating Central Nervous System conditions, and medicaments employed in treating hepatitis.
  • the term medicament also encompasses pharmaceutically acceptable salts, esters, solvates, and/or hydrates of the pharmaceutically active substances referred to hereinabove.
  • an oral pharmaceutical formulation typically refers to the combination of at least one medicament and one or more added components or elements, such as an "excipient” or “carrier.”
  • excipient and carrier generally refer to substantially inert materials that are nontoxic and do not interact with other components of the composition in a deleterious manner.
  • excipients include pharmaceutical grades of carbohydrates, including monosaccharides, disaccharides, cyclodextrins and polysacchahdes (e.g., dextrose, sucrose, lactose, raffinose, mannitol, sorbitol, inositol, dexthns and maltodextrins); starch; cellulose; salts (e.g., sodium or calcium phosphates, calcium sulfate, magnesium sulfate); citric acid; tartaric acid; glycine; leucine; high molecular weight polyethylene glyols (PEG); pluronics; surfactants; lubricants; stearates and their salts or esters (e.g., magnesium stearate); amino acids; fatty acids; and combinations thereof.
  • FIGS. 1a and 1b depict an embodiment of a packaging system 10 according to the present invention. As shown, the system 10 is present as a unitary structure and includes an outer container 20. In this embodiment, outer container 20 has a cross-sectional area 30 that is circular shaped.
  • the outer container 20 includes a flange 40 and a container wall 50 extending downwardly from flange 40 and throughout the periphery of the flange 40.
  • the bottom of the container wall 50 is left unclosed such that it is open to the external environment, accordingly, a void space 60 is formed within the container wall 50.
  • an inner container within the void space 60, and as shown in FIG. 1a, an inner container
  • the diameter of the inner container (d) may be selected from various sizes. For example, in one embodiment, the diameter may range from about 1 cm to about 10 cm.
  • a first portion 80 of the inner container 70 extends below flange 40 and into the void space 60 and a second portion 90 extending above the flange 40.
  • a package outsell (depicted as 65) may be present in the void space 60 formed between the inner container 70 and the outer container 20.
  • the inner container 70 includes a neck 100 having a base portion 110. As depicted in FIG. 1, the flange 40 is attached to inner container 70 at base portion 110 such that the outer container 20 and the inner container 70 are joined and thus present as a unitary structure.
  • FIG. 1 the diameter of the inner container 70 is present.
  • FIG. 2 represents a perspective view of the packaging system 10 illustrated in cross-section in FIG. 1.
  • a bottle label 120 may be present on outer surface 130 of outer container 20.
  • a microelectronic chip having an antenna associated therewith shown in FIG. 5 as 140 can be attached to outer surface 130.
  • FIGS. 1a, 1b, and 2 depict the cross-section of outer container 20 being circular shaped. It should be appreciated that, for the purposes of the invention, outer container may have other cross-sectional configurations including, without limitation, circular, triangular, heptagonal, hexagonal, octahedral, etc. As an example, FIGS. 3a, 3b and 4 depict the cross-section of outer container 20 being rectangular (e.g., square) shaped.
  • FIG. 5 illustrates an array 10' of packaging systems 10 having square cross-sectional areas. As shown, caps 150 are present on the packaging systems 10.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Ceramic Engineering (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)

Abstract

The present invention relates to a packaging system (10) including an outer container (20) and an inner container (70) present within the outer container. A void space (60) is present between the outer container (20) and the inner container (70) for receiving an outsert (65).

Description

MEDICAMENT HOUSING APPARATUS HAVING OUTER AND INNER CONTAINERS
Field and Background of the Invention The invention generally relates to packaging for housing medicament. Numerous examples of packaging pharmaceutical medicament present in oral dosage form are disclosed. Specific examples include those intended to accommodate packaging a variety of predetermined volumes of medicament. To illustrate further, U.S. Patent Nos. 5,315,81 1 ; 5,197,602; and 6,243,936 disclose packaging systems for containing materials therein, and methods for assembling packaging systems for containing materials. Notwithstanding any potential advantages offered by the above- proposed packaging systems, such systems may be potentially complicated from an assembling perspective in that an individual packaging system is made up of multiple components. It would be desirable to obtain a packaging system that is simpler in structure, thus having the potential to reduce multiple steps in assembling a conventional packaging system.
Summary of the Invention In view of the above, and in one aspect, the present invention provides a packaging system. The packaging system includes a plurality of substantially uniformly shaped containers comprising an outer container and an inner container present within the outer container. The outer container includes a flange and a container wall attached thereto and extending downwardly from the flange. The inner container includes a container wall and a bottom portion attached to the container wall which closes the inner container. Both the outer container and the inner container each have respective cross-sections. The outer container has a bottom portion that is not enclosed, and a void space is present between the outer container and the inner container. The inner container further includes a neck having a base portion and wherein the flange of said outer container is attached to the base portion. As a result, and advantageously, the outer container and the inner container are a unitary structure.
Brief Description of the Drawings FIGS. 1a and 1b respectively are side and bottom cross-sectional views of an embodiment of the packaging system. FIG. 2 is a perspective view of an embodiment of the packaging system. FIGS. 3a and 3b respectively are side and bottom cross-sectional views of an embodiment of the packaging system. FIG. 4 is a perspective view of an embodiment of the packaging system. FIG. 5 is a perspective view of an embodiment of an array of packaging systems.
Detailed Description of the Embodiments The present invention will now be described in reference to the embodiments set forth herein, including, without limitation, those described in the drawings. It should be appreciated that these embodiments are for illustrative purposes only, and are not intended to limit the scope of the invention as defined by the claims. All publications, patents, and patent applications cited herein, whether supra or infra, are hereby incorporated herein by reference in their entirety to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference. It must be noted that, as used in the specification and appended claims, the singular forms "a", "an", "the", and "one" may include plural referents unless the content clearly dictates otherwise. A number of materials may be employed in forming the outer and inner containers of the invention. For example, these may be formed from a polymer, preferably one or more thermoplastic polymers. Exemplary polymers include at least one material such as, without limitation, polyvinyl chloride, polyvinylidene chloride, polypropylene, polyethylene, polychlorotrifluoroethylene, and combinations thereof. The packaging system of the present invention may be fabricated by employed accepted techniques such as, without limitation, injection molding. At least one medicament may be housed in the packaging system of the present invention. For the purposes of the invention, the term "medicament", as used herein, is meant to mean and include any substance (i.e., compound or composition of matter) which, when administered to an organism (human or animal) induces a desired pharmacologic and/or physiologic effect by local and/or systemic action. The term therefore encompasses substances traditionally regarded as actives, drugs and bioactive agents, as well as biopharmaceuticals (e.g., peptides, hormones, nucleic acids, gene constructs, etc.) typically employed to treat a number of conditions which is defined broadly to encompass diseases, disorders, infections, and the like. Exemplary medicaments include, without limitation, antibiotics, antivirals, H2-receptor antagonists, 5HTι agonists, 5HT3 antagonists, COX2-inhibitors, medicaments used in treating psychiatric conditions such as depression, anxiety, bipolar condition, tranquilizers , medicaments used in treating metabolic conditions, anticancer medicaments, medicaments used in treating neurological conditions such as epilepsy and Parkinsons Disease, medicaments used in treating cardiovascular conditions, non-steroidal anti-inflammatory medicaments, medicaments used in treating Central Nervous System conditions, and medicaments employed in treating hepatitis. The term medicament also encompasses pharmaceutically acceptable salts, esters, solvates, and/or hydrates of the pharmaceutically active substances referred to hereinabove. Various combinations of any of the above medicaments may also be employed. In accordance with the present invention, the medicament is typically employed in an oral pharmaceutical formulation. An oral pharmaceutical formulation typically refers to the combination of at least one medicament and one or more added components or elements, such as an "excipient" or "carrier." As will be appreciated by one having ordinary skill in the art, the terms "excipient" and "carrier" generally refer to substantially inert materials that are nontoxic and do not interact with other components of the composition in a deleterious manner. Examples of normally employed "excipients," include pharmaceutical grades of carbohydrates, including monosaccharides, disaccharides, cyclodextrins and polysacchahdes (e.g., dextrose, sucrose, lactose, raffinose, mannitol, sorbitol, inositol, dexthns and maltodextrins); starch; cellulose; salts (e.g., sodium or calcium phosphates, calcium sulfate, magnesium sulfate); citric acid; tartaric acid; glycine; leucine; high molecular weight polyethylene glyols (PEG); pluronics; surfactants; lubricants; stearates and their salts or esters (e.g., magnesium stearate); amino acids; fatty acids; and combinations thereof. The oral pharmaceutical formulation may be utilized in a variety of unit dosage forms including, without limitation, a tablet, a pill, a capsule, a lozenge, and combinations thereof. The unit dosage forms may encompass hospital unit dosage forms, as well as others. The invention will now be described with respect to the drawings. It should be appreciated that the drawings are merely set forth to illustrate the invention and do not serve to limit the scope of the invention as defined by the claims. FIGS. 1a and 1b depict an embodiment of a packaging system 10 according to the present invention. As shown, the system 10 is present as a unitary structure and includes an outer container 20. In this embodiment, outer container 20 has a cross-sectional area 30 that is circular shaped. The outer container 20 includes a flange 40 and a container wall 50 extending downwardly from flange 40 and throughout the periphery of the flange 40. The bottom of the container wall 50 is left unclosed such that it is open to the external environment, accordingly, a void space 60 is formed within the container wall 50. Within the void space 60, and as shown in FIG. 1a, an inner container
70 is present. The diameter of the inner container (d) may be selected from various sizes. For example, in one embodiment, the diameter may range from about 1 cm to about 10 cm. A first portion 80 of the inner container 70 extends below flange 40 and into the void space 60 and a second portion 90 extending above the flange 40. A package outsell (depicted as 65) may be present in the void space 60 formed between the inner container 70 and the outer container 20. The inner container 70 includes a neck 100 having a base portion 110. As depicted in FIG. 1, the flange 40 is attached to inner container 70 at base portion 110 such that the outer container 20 and the inner container 70 are joined and thus present as a unitary structure. Optionally, and as shown in FIG. 1 , the neck 100 of the inner container 70 may be configured to accommodate a cap. In this embodiment, threads 115 present such that a corresponding cap (not shown) can fit thereon. It should also be appreciated that other configurations may be used in place of, or in combination with threads such as, without limitation, helical locks, lug locks, and the like. FIG. 2 represents a perspective view of the packaging system 10 illustrated in cross-section in FIG. 1. As shown, in this particular embodiment, a bottle label 120 may be present on outer surface 130 of outer container 20. Also, in place of, or in addition to label 120, a microelectronic chip having an antenna associated therewith (shown in FIG. 5 as 140) can be attached to outer surface 130. Chip 140 is advantageous in that it allows for the electronic storage and retrieval of information relevant to the product housed within packaging system 10. FIGS. 1a, 1b, and 2 depict the cross-section of outer container 20 being circular shaped. It should be appreciated that, for the purposes of the invention, outer container may have other cross-sectional configurations including, without limitation, circular, triangular, heptagonal, hexagonal, octahedral, etc. As an example, FIGS. 3a, 3b and 4 depict the cross-section of outer container 20 being rectangular (e.g., square) shaped. FIG. 5 illustrates an array 10' of packaging systems 10 having square cross-sectional areas. As shown, caps 150 are present on the packaging systems 10. Such an embodiment is believed to be advantageous in that it allows for multiple packaging systems to be stored and/or transported in configuration with minimal wasted space between packaging systems, and minimal movement of the packaging systems. The present invention has been described with respect to the embodiments set forth herein. Nonetheless, it should be noted that such embodiments are merely set forth to illustrate the invention, and do not limit its scope as defined by the claims set forth herein.

Claims

THAT WHICH IS CLAIMED: 1. A packaging system comprising: a plurality of substantially uniformly shaped containers comprising an outer container and an inner container present within said outer container, said outer container including a flange and a container wall attached thereto and extending downwardly from the flange, said inner container including a container wall and a bottom portion attached to the container wall which closes the inner container, said outer container and said inner container each having respective cross-sections; said outer container having a bottom portion that is not enclosed, wherein a void space is present between the outer container and the inner container; and said inner container further including a neck having a base portion and wherein the flange of said outer container is attached to the base portion such that said outer container and said inner container are a unitary structure.
2. The packaging system according to Claim 1 , wherein a package outsell is positioned in the void space between the outer container and the inner container.
3. The packaging system according to Claim 1 , wherein the neck of said inner container is configured to accommodate a bottle cap.
4. The packaging system according to Claim 1 , wherein said outer container and said inner container are formed from a polymer.
5. The packaging system according to Claim 4, wherein the polymer comprises at least one material selected from the group consisting of polyvinyl chloride, polyvinylidene chloride, polypropylene, polyethylene, polychlorotrifluoroethylene, and combinations thereof.
6. The packaging system according to Claim 1 , wherein the inner diameter ranges in size from about 1 cm to about 10 cm.
7. The packaging system according to Claim 1 , wherein at least one medicament is housed in said packaging system.
8. The packaging system according to Claim 7, wherein the at least one medicament is selected from the group consisting of antibiotics, antivirals, h -receptor antagonists, 5HTι agonists, 5HT3 antagonists, COX2- inhibitors, medicaments used in treating psychiatric conditions, medicaments used in treating metabolic conditions, anticancer medicaments, medicaments used in treating neurological conditions, medicaments used in treating cardiovascular conditions, non-steroidal anti-inflammatories medicaments, medicaments used in treating Central Nervous System conditions, and medicaments employed in treating Hepatitis B and C.
9. The packaging system according to Claim 1 , wherein the cross- section of the inner container is circular.
10. The packaging system according to Claim 1 , wherein the cross- section of the outer container is circular
11. The packaging system according to Claim 1 , wherein the cross- section of the outer container is square.
12. A packaging system comprising: a plurality of substantially uniformly shaped containers of different diameters, said plurality of substantially uniformly shaped containers comprising an outer container having a first diameter and an inner container having a second diameter smaller relative to the first diameter, said inner container being present within said outer container, said outer container including a flange and a container wall attached thereto and extending downwardly from the flange, said inner container including a container wall and a bottom portion attached to the container wall which closes the inner container, wherein said inner container houses at least one medicament therein; said outer container having a bottom portion that is not enclosed, wherein a void space is present between the outer container and the inner container; and said inner container further including a neck having a base portion and wherein the flange of said outer container is attached to the base portion such that said outer container and said inner container are a unitary structure, and wherein the neck is configured to accommodate a bottle cap.
13. The packaging system according to Claim 12, wherein a package outsell is positioned in the void space between the outer container and the inner container.
14. The packaging system according to Claim 12, wherein said outer container and said inner container are formed from a polymer.
15. The packaging system according to Claim 14, wherein the polymer comprises at least one material selected from the group consisting of polyvinyl chloride, polyvinylidene chloride, polypropylene, polyethylene, polychlorotrifluoroethylene, and combinations thereof.
16. The packaging system according to Claim 12, wherein the inner diameter ranges in size from about 1 cm to about 10 cm.
17. The packaging system according to Claim 12, wherein the at least one medicament is selected from the group consisting of antibiotics, antivirals, H2-receptor antagonists, 5HTι agonists, 5HT3 antagonists, COX2- inhibitors, medicaments used in treating psychiatric conditions, medicaments used in treating metabolic conditions, anticancer medicaments, medicaments used in treating neurological conditions, medicaments used in treating cardiovascular conditions, non-steroidal anti-inflammatories medicaments, medicaments used in treating Central Nervous System conditions, and medicaments employed in treating Hepatitis B and C.
18. The packaging system according to Claim 12, wherein the cross-section of the inner container is circular.
19. The packaging system according to Claim 12, wherein the cross-section of the outer container is circular
20. The packaging system according to Claim 12, wherein the cross-section of the outer container is square.
21. An array of packaging systems for housing medicament therein, wherein each of the packaging systems are defined according to Claim 1.
EP05749362A 2004-05-21 2005-05-16 Medicament housing apparatus having outer and inner containers Withdrawn EP1755978A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57345304P 2004-05-21 2004-05-21
PCT/US2005/017027 WO2005115869A1 (en) 2004-05-21 2005-05-16 Medicament housing apparatus having outer and inner containers

Publications (1)

Publication Number Publication Date
EP1755978A1 true EP1755978A1 (en) 2007-02-28

Family

ID=35450766

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05749362A Withdrawn EP1755978A1 (en) 2004-05-21 2005-05-16 Medicament housing apparatus having outer and inner containers

Country Status (6)

Country Link
US (1) US20070209331A1 (en)
EP (1) EP1755978A1 (en)
JP (1) JP2008500133A (en)
CA (1) CA2566313A1 (en)
IL (1) IL179034A0 (en)
WO (1) WO2005115869A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009007511A (en) * 2007-01-20 2009-07-21 Merck Patent Gmbh Packaging containing soft capsules.
CN111056122A (en) * 2020-01-16 2020-04-24 中船第九设计研究院工程有限公司 Sanitary anti-pollution type packaging container
US12409997B2 (en) * 2020-05-05 2025-09-09 Alla Hussein ABDELHAMID Container for storing perishable contents and method of making same
JP2023553284A (en) * 2020-11-20 2023-12-21 エスアイオーツー・メディカル・プロダクツ・インコーポレイテッド Polymer vials with standard external dimensions and reduced internal volume

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2000419A (en) * 1934-01-18 1935-05-07 Emery N Sarber Advertising condiment shaker
US2493922A (en) * 1945-02-13 1950-01-10 Coeur Company Container
US2945314A (en) * 1957-10-17 1960-07-19 Brian E Baldwin Display device
US3374911A (en) * 1967-05-15 1968-03-26 Robert V. White Plastic cosmetic jar
US4871077A (en) * 1987-04-27 1989-10-03 Doxtech, Inc. Tamper resistant, tamper evident leak proof container
US5197602A (en) * 1991-05-30 1993-03-30 Drug Plastics & Glass Company, Inc. Packing system comprising a plurality of outer containers having container inserts therein for holding a predetermined volume of material
US5315811A (en) * 1991-05-30 1994-05-31 Drug Plastics & Glass Company, Inc. Method of packaging with an outer container having a container insert for holding a predetermined volume of material
US6243936B1 (en) * 1991-05-30 2001-06-12 Drug Plastics And Glass Company, Inc. Method for assembling an outer container having a container insert therein for holding a predetermined volume of material
US5318183A (en) * 1991-09-19 1994-06-07 Glaxo, Inc. Bottle with insert to reduce effective volume
GB9519196D0 (en) * 1995-09-20 1995-11-22 Jaycare Ltd Improvements relating to packaging containers
US6076697A (en) * 1997-06-09 2000-06-20 Allabaugh, Jr.; Robert Carleton Crate for cartons
JP4462689B2 (en) * 2000-01-18 2010-05-12 株式会社トーショー Chemical storage device
US6360462B1 (en) * 2000-04-10 2002-03-26 Mcneil-Ppc, Inc. Container with label
US6301812B1 (en) * 2000-09-19 2001-10-16 Richard Klunk Gift container and associated methods
US20030071040A1 (en) * 2001-10-17 2003-04-17 Olcott Plastics Jar container and method of making same
US20040045863A1 (en) * 2002-09-06 2004-03-11 Rhoades Dean L. Container with extractable and retractable instructions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2005115869A1 *

Also Published As

Publication number Publication date
US20070209331A1 (en) 2007-09-13
CA2566313A1 (en) 2005-12-08
WO2005115869A1 (en) 2005-12-08
JP2008500133A (en) 2008-01-10
IL179034A0 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
US8443977B2 (en) Blister package apparatus and methods for tablets
JP7424758B2 (en) Holding structures for simultaneously holding multiple containers for substances used for pharmaceutical, medical or cosmetic purposes as well as transport structures with holding structures
US5318183A (en) Bottle with insert to reduce effective volume
EP2659980B1 (en) Support structure for simultaneously holding a plurality of medical or pharmaceutical containers and transport or packaging container with the same
CA2541021C (en) Container with pill dispensing insert
CA1197818A (en) Dry pharmaceutical system
JPH08503155A (en) Method of freeze-drying and sealing similar to freeze-dried compound cartridge assembly forming the disposable portion of an injector pen
TWI794137B (en) Affixed groups of pharmaceutical vials including frangible connectors
US11396413B2 (en) One or more blister packages containing active material and methods of making and using same
WO1995016428A1 (en) A combination pill crushing and dispensing cup
US20100183776A1 (en) Water bottle with dosage in a blister pack
US10675217B2 (en) Spherical pill container with domed lid
SK282868B6 (en) Biconvex rapidly disintegrating dosage forms
US20110147252A1 (en) Packages and inserts useful for dispensing medicines
US20070209331A1 (en) Medicament housing apparatus having outer and inner containers
US20090095647A1 (en) Injector Piston Nest
WO2002013762A3 (en) Improved solid pharmaceutical dosage formulation of hydrophobic drugs
WO1996039343A1 (en) Container for separately holding a material and desiccant
US20080257905A1 (en) Dispensing Apparatus for Diagnostic Test Strip and/or Medicine
US20130152515A1 (en) Tablet storage system and use thereof
WO1999025629A1 (en) Multicompartment container for combination products
KR20180002020U (en) Tablet container
WO2005112672A1 (en) Tablet dispenser insert for stacked tablets
KR20250152012A (en) Cartridge nest, which features integrated centering of the cartridges
JP2023002426A (en) Containers and Dispensed Products

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061117

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: HR LV

RAX Requested extension states of the european patent have changed

Extension state: LV

Payment date: 20061117

Extension state: HR

Payment date: 20061117

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GLAXOSMITHKLINE LLC

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20101201